Two research houses trimmed their price targets on Cerebras Systems on Monday while leaving their buy-equivalent ratings untouched, and the same day a large block of Class A stock became freely tradable. For anyone holding the name, those two developments point at the same question: how much of the bull case rests on analyst conviction, and how much still has to be earned in the numbers?
Wedbush cut its target to $190 from $290, keeping an Outperform rating, and pointed to falling valuation multiples across semiconductor and hardware stocks. Morgan Stanley moved in parallel, lowering its target to $178 from $279 while sticking with Overweight. Both firms, in other words, still like the company — they just value it less generously than before.
Lockup Ends, Insiders Sell
Monday also marked the expiry of contractual holding restrictions, freeing roughly 71.4% of Cerebras’ Class A shares for trading, according to a report from The Inference. The enlarged float arrived alongside a disclosure that Chief Technology Officer Sean Lie and Chief Operating Officer Dhiraj Mallick had sold shares worth about $228 million combined ahead of the lockup deadline, through pre-arranged trading plans.
The quarter’s headline numbers land on November 12 after the US close, and they will be read against a demanding backdrop. Management has guided to core revenue of $214 million to $216 million for the third quarter of 2026, a gross margin of 38% to 40% in the core business, and an operating margin of minus 25% to minus 23%.
That operating loss is the crux of the cautious case. Revenue at the top of the range would only be a strong argument if margins hold up alongside it, and the guidance currently pairs healthy top-line growth with a business that is still burning money at the operating line. Investors would do well to weigh the two figures together rather than treating the revenue range as a verdict on its own.
A $25.4 Billion Backlog and One Big Name
Underneath the quarterly guidance sits a much larger promise. Cerebras put its remaining performance obligations at $25.4 billion as of the end of the second quarter of 2026, with the overwhelming majority attributable to OpenAI, according to The Inference. The figure speaks to the scale of the opportunity — provided the company can deliver the contracted capacity at a viable economic return.
Should investors sell immediately? Or is it worth buying CEREBRAS SYSTEMS INC - A?
That customer concentration cuts both ways. A backlog of that size can underwrite expansion, but it also ties the valuation tightly to a single counterparty, which makes execution and margin progression the metrics that matter most. Capacity announcements are only half the story; the other half is what those deployments earn.
The Durability Dispute
How long the hardware actually lasts has become a valuation question in its own right. Culper Research alleged on October 28 that the company’s wafers have a functional lifespan of just 1.5 to 2.5 years, and also took aim at the accounting assumptions behind Cerebras’ depreciation schedule. Cerebras rejected the claim; per The Inference, the chief executive said fewer than 0.5% of the CS-3 wafers deployed have been retired.
The dispute has drawn legal attention. Pomerantz said Monday it is investigating possible securities violations by Cerebras and its executives, and its probe takes up the Culper allegations as well. That raises the premium on verifiable disclosure about both the technology and the accounting.
What to Watch on November 12
The coming earnings report offers the next real checkpoint. The yardstick worth applying is the combination of margin, capacity build-out and a defensible view of equipment life — the three pieces that determine whether the capital being deployed earns an adequate return. Analyst enthusiasm and a freshly unlocked share count can move the stock in the near term, but neither settles that arithmetic. Cerebras can capitalize on the build-out of AI infrastructure if its systems last and its contracts pay; how much patience the long-term story deserves hinges on exactly that.
Ad
CEREBRAS SYSTEMS INC - A Stock: Buy or Sell?! New CEREBRAS SYSTEMS INC - A Analysis from November 12 delivers the answer:
The latest CEREBRAS SYSTEMS INC - A figures speak for themselves: Urgent action needed for CEREBRAS SYSTEMS INC - A investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 12.
CEREBRAS SYSTEMS INC - A: Buy or sell? Read more here...
